Iron Deficiency in Acute Coronary Syndromes-Clinical Correlates and Outcomes
Gabriele Masini1, Matilde Barsacchi1, Simona Chiusolo1
1Chair and Postgraduate School of Cardiology, University of Pisa and Cardiovascular Division 1, Pisa University Hospital, Pisa, Italy.
Insights
Iron deficiency is common in acute coronary syndromes, impacting prognosis. Different definitions reveal varying prevalence and associations with worse left ventricular function and inflammation.
Area of Science:
- Cardiology
- Internal Medicine
- Biochemistry
Background:
- Iron deficiency is prevalent in heart failure, linked to poor outcomes.
- Its role in acute coronary syndromes (ACS) remains unclear.
- This study investigates iron deficiency in ACS patients.
Purpose of the Study:
- Assess iron deficiency prevalence in ACS patients.
- Correlate iron deficiency with infarct size and left ventricular function.
- Examine associations with in-hospital and post-discharge events.
Main Methods:
- Analyzed 152 ACS patients using multiple iron deficiency criteria.
- Defined deficiency by serum iron, transferrin saturation (TSAT), ferritin, and combined criteria.
- Assessed infarct size via peak cardiac troponin T and used Cox regression for event analysis.
Main Results:
- Iron deficiency prevalence varied from 21% to 62% by definition.
- Deficiency by serum iron or TSAT correlated with lower ejection fraction, not infarct size.
- Lower serum iron predicted post-discharge events, though not after hs-CRP adjustment; lower ferritin predicted fewer events.
Conclusions:
- Iron deficiency is frequent in acute coronary syndromes.
- Serum iron and TSAT definitions identify patients with poorer left ventricular function and increased inflammation.
- These factors may influence patient prognosis.
Background:
Iron deficiency is common in heart failure and relates to a worse prognosis, but its role in acute coronary syndromes is unclear. This study assessed iron deficiency prevalence, correlation with infarct size and left ventricular function, and association with in-hospital and post-discharge events in such patients.
Methods:
We analyzed 152 acute coronary syndrome patients using multiple iron deficiency definitions: serum iron <6 µmol/L or <13 µmol/L; transferrin saturation (TSAT) <20%; ferritin <100 µg/L; and a combined definition - ferritin <100 µg/L or TSAT<20% if ferritin 100-299 µg/L. Infarct size was approximated by peak cardiac troponin T. Cox regression analysis examined associations with in-hospital complications (death, sustained arrhythmias, or Killip class ≥3) and post-discharge events (death, myocardial infarction, or stroke).
Results:
The prevalence of iron deficiency ranged from 21% to 62%, depending on definitions. Patients with deficiency defined by serum iron or TSAT were older, more frequently female, with more cardiovascular risk factors, and higher high-sensitivity C-reactive protein. Serum iron <13 µmol/L and TSAT <20% correlated with lower left ventricular ejection fraction but not with greater infarct size. Iron deficiency did not predict in-hospital complications, whereas serum iron <6 µmol/L was associated with a higher risk of post-discharge events. Such association lost significance after adjustment for hs-CRP. Lower ferritin predicted fewer events.
Conclusion:
Iron deficiency is frequent in acute coronary syndromes. Definitions by serum iron and TSAT identify patients with worse left ventricular systolic function and more inflammation, potentially influencing prognosis.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
05:35Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
